Deferoxamine mesylate (Gland Pharma Limited)
Welcome to the PulseAid listing for the Deferoxamine mesylate drug offered from Gland Pharma Limited. This Iron Chelating Activity [MoA],Iron Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gland Pharma Limited |
NON-PROPRIETARY NAME: | Deferoxamine mesylate |
SUBSTANCE NAME: | DEFEROXAMINE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-09 |
END MARKETING DATE: | 0000-00-00 |
Deferoxamine mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Deferoxamine mesylate from Gland Pharma Limited |
LABELER NAME: | Gland Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2017-10-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68083-172_2d0db797-db19-4c14-ba7e-0fcfff1affe5 |
PRODUCT NDC: | 68083-172 |
APPLICATION NUMBER: | ANDA207384 |
Other DEFEROXAMINE MESYLATE Pharmaceutical Manufacturers / Labelers: